+1(510) 988-0024
Persistent insomnia (disturbance in the sleeping pattern) has been linked with adverse long-term health outcomes, including diminished quality of life and physical and psychological disorders. In the past decade,
essential changes in classification and diagnostic paradigms have instigated a move from a purely symptom-based conceptualization to recognizing insomnia as a disorder in its own right. These changes have been paralleled by crucial some in therapy, with generic pharmacological and psychological ways being increasingly replaced by approaches with sleep-specific and insomnia-specific therapeutic targets. Psychological and pharmacological treatments effectively decrease the time it takes to fall asleep and the time spent awake after sleep on time and produce a primarily increase in total sleep time; these outcomes relate to improvements in daytime functioning. Despite this Improvement, several challenges remain, including the need to improve our knowledge of the mechanisms that underlie insomnia and develop more cost-effective, efficient, and accessible therapies.